Carolina Wealth Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.48K Hold
9
﹤0.01% 255
2026
Q1
$2.63K Hold
9
﹤0.01% 252
2025
Q4
$3.15K Hold
9
﹤0.01% 214
2025
Q3
$2.91K Hold
9
﹤0.01% 198
2025
Q2
$3.5K Hold
9
﹤0.01% 202
2025
Q1
$3.92K Hold
9
﹤0.01% 202
2024
Q4
$3.32K Hold
9
﹤0.01% 223
2024
Q3
$4.68K Hold
9
﹤0.01% 238
2024
Q2
$4.88K Hold
9
﹤0.01% 168
2024
Q1
$4.67K Hold
9
﹤0.01% 176
2023
Q4
$4.24K Hold
9
﹤0.01% 188
2023
Q3
$3.92K Hold
9
﹤0.01% 200
2023
Q2
$4K Hold
9
﹤0.01% 193
2023
Q1
$4.14K Hold
9
﹤0.01% 189
2022
Q4
$5K Hold
9
﹤0.01% 171
2022
Q3
$4K Hold
9
﹤0.01% 178
2022
Q2
$4K Hold
9
﹤0.01% 201
2022
Q1
$4K Hold
9
﹤0.01% 213
2021
Q4
$4K Hold
9
﹤0.01% 219
2021
Q3
$3K Hold
9
﹤0.01% 227
2021
Q2
$3K Hold
9
﹤0.01% 249
2021
Q1
$3K Hold
9
﹤0.01% 268
2020
Q4
$3K Sell
9
-14
-61% -$4.3K ﹤0.01% 199
2020
Q3
$6K Buy
+23
New +$6.19K 0.01% 162

Other funds holding ELV

Carolina Wealth Advisors's ELV Position: Q2 2026 in Review

Carolina Wealth Advisors held its Elevance Health (ELV) position steady in Q2 2026 at 9 shares worth $3.48K. The position accounts for ﹤0.01% of the portfolio, ranked #255.

Carolina Wealth Advisors first reported a position in ELV in Q3 2020 and has held it in 24 quarters since. The position peaked at $6K in Q3 2020. 1,602 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Carolina Wealth Advisors held 9 shares of Elevance Health worth $3.48K as of Q2 2026.
  • Carolina Wealth Advisors left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up ﹤0.01% of Carolina Wealth Advisors's portfolio in Q2 2026, its #255 holding.
  • Carolina Wealth Advisors first reported a position in Elevance Health in Q3 2020 and has held it in 24 quarters since.
  • Carolina Wealth Advisors's Elevance Health position peaked at $6K in Q3 2020.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Carolina Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.